Shares of Becton Dickinson & Co. BDX slipped 1.11% to $224.92 Tuesday, on what proved to be an all-around grim trading ...

The stock's rise snapped a four-day losing streak.

Becton, Dickinson and Company (NYSE:BDX – Get Free Report)’s stock price fell 0.3% during trading on Thursday following insider selling activity. The company traded as low as $222.01 and last traded ...

Medical-device maker Becton Dickinson and Co. accused a former area sales director of bolting to a competitor in violation of ...

Becton, Dickinson and Company (NYSE:BDX – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold ...

Learn more about whether Becton, Dickinson and Company or GE HealthCare Technologies Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics ...

A new study found that 9.1% of medical device AEs were reported to the FDA 180 days later than required over a three-year ...

On Tuesday, 11 March 2025, Becton Dickinson (NYSE: BDX) presented at the Barclays 27th Annual Global Healthcare Conference, outlining its strategic focus on separating its Life Sciences business ...

The Rising Need for Efficient and Effective Drug Discoveries Worldwide is Expected to Create Lucrative Growth Opportunities in the Market.

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Citi analyst Joanne Wuensch reiterated a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed yesterday at ...

Detailed price information for Zimmer Biomet Holdings (ZBH-N) from The Globe and Mail including charting and trades.